Cargando…
An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen
Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens. We tested the ability of an anti-tick vaccine derived from a tick cement protein (64TRP) of Rhipicephalus appendiculatus to prot...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1424664/ https://www.ncbi.nlm.nih.gov/pubmed/16604154 http://dx.doi.org/10.1371/journal.ppat.0020027 |
_version_ | 1782127186143084544 |
---|---|
author | Labuda, Milan Trimnell, Adama R Ličková, Martina Kazimírová, Mária Davies, Gillian M Lissina, Olga Hails, Rosie S Nuttall, Patricia A |
author_facet | Labuda, Milan Trimnell, Adama R Ličková, Martina Kazimírová, Mária Davies, Gillian M Lissina, Olga Hails, Rosie S Nuttall, Patricia A |
author_sort | Labuda, Milan |
collection | PubMed |
description | Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens. We tested the ability of an anti-tick vaccine derived from a tick cement protein (64TRP) of Rhipicephalus appendiculatus to protect mice against tick-borne encephalitis virus (TBEV) transmitted by infected Ixodes ricinus ticks. The vaccine has a “dual action” in immunized animals: when infested with ticks, the inflammatory and immune responses first disrupt the skin feeding site, resulting in impaired blood feeding, and then specific anti-64TRP antibodies cross-react with midgut antigenic epitopes, causing rupture of the tick midgut and death of engorged ticks. Three parameters were measured: “transmission,” number of uninfected nymphal ticks that became infected when cofeeding with an infected adult female tick; “support,” number of mice supporting virus transmission from the infected tick to cofeeding uninfected nymphs; and “survival,” number of mice that survived infection by tick bite and subsequent challenge by intraperitoneal inoculation of a lethal dose of TBEV. We show that one dose of the 64TRP vaccine protects mice against lethal challenge by infected ticks; control animals developed a fatal viral encephalitis. The protective effect of the 64TRP vaccine was comparable to that of a single dose of a commercial TBEV vaccine, while the transmission-blocking effect of 64TRP was better than that of the antiviral vaccine in reducing the number of animals supporting virus transmission. By contrast, the commercial antitick vaccine (TickGARD) that targets only the tick's midgut showed transmission-blocking activity but was not protective. The 64TRP vaccine demonstrates the potential to control vector-borne disease by interfering with pathogen transmission, apparently by mediating a local cutaneous inflammatory immune response at the tick-feeding site. |
format | Text |
id | pubmed-1424664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-14246642006-05-01 An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen Labuda, Milan Trimnell, Adama R Ličková, Martina Kazimírová, Mária Davies, Gillian M Lissina, Olga Hails, Rosie S Nuttall, Patricia A PLoS Pathog Research Article Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens. We tested the ability of an anti-tick vaccine derived from a tick cement protein (64TRP) of Rhipicephalus appendiculatus to protect mice against tick-borne encephalitis virus (TBEV) transmitted by infected Ixodes ricinus ticks. The vaccine has a “dual action” in immunized animals: when infested with ticks, the inflammatory and immune responses first disrupt the skin feeding site, resulting in impaired blood feeding, and then specific anti-64TRP antibodies cross-react with midgut antigenic epitopes, causing rupture of the tick midgut and death of engorged ticks. Three parameters were measured: “transmission,” number of uninfected nymphal ticks that became infected when cofeeding with an infected adult female tick; “support,” number of mice supporting virus transmission from the infected tick to cofeeding uninfected nymphs; and “survival,” number of mice that survived infection by tick bite and subsequent challenge by intraperitoneal inoculation of a lethal dose of TBEV. We show that one dose of the 64TRP vaccine protects mice against lethal challenge by infected ticks; control animals developed a fatal viral encephalitis. The protective effect of the 64TRP vaccine was comparable to that of a single dose of a commercial TBEV vaccine, while the transmission-blocking effect of 64TRP was better than that of the antiviral vaccine in reducing the number of animals supporting virus transmission. By contrast, the commercial antitick vaccine (TickGARD) that targets only the tick's midgut showed transmission-blocking activity but was not protective. The 64TRP vaccine demonstrates the potential to control vector-borne disease by interfering with pathogen transmission, apparently by mediating a local cutaneous inflammatory immune response at the tick-feeding site. Public Library of Science 2006-04 2006-04-07 /pmc/articles/PMC1424664/ /pubmed/16604154 http://dx.doi.org/10.1371/journal.ppat.0020027 Text en © 2006 Labuda et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Labuda, Milan Trimnell, Adama R Ličková, Martina Kazimírová, Mária Davies, Gillian M Lissina, Olga Hails, Rosie S Nuttall, Patricia A An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen |
title | An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen |
title_full | An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen |
title_fullStr | An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen |
title_full_unstemmed | An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen |
title_short | An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen |
title_sort | antivector vaccine protects against a lethal vector-borne pathogen |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1424664/ https://www.ncbi.nlm.nih.gov/pubmed/16604154 http://dx.doi.org/10.1371/journal.ppat.0020027 |
work_keys_str_mv | AT labudamilan anantivectorvaccineprotectsagainstalethalvectorbornepathogen AT trimnelladamar anantivectorvaccineprotectsagainstalethalvectorbornepathogen AT lickovamartina anantivectorvaccineprotectsagainstalethalvectorbornepathogen AT kazimirovamaria anantivectorvaccineprotectsagainstalethalvectorbornepathogen AT daviesgillianm anantivectorvaccineprotectsagainstalethalvectorbornepathogen AT lissinaolga anantivectorvaccineprotectsagainstalethalvectorbornepathogen AT hailsrosies anantivectorvaccineprotectsagainstalethalvectorbornepathogen AT nuttallpatriciaa anantivectorvaccineprotectsagainstalethalvectorbornepathogen AT labudamilan antivectorvaccineprotectsagainstalethalvectorbornepathogen AT trimnelladamar antivectorvaccineprotectsagainstalethalvectorbornepathogen AT lickovamartina antivectorvaccineprotectsagainstalethalvectorbornepathogen AT kazimirovamaria antivectorvaccineprotectsagainstalethalvectorbornepathogen AT daviesgillianm antivectorvaccineprotectsagainstalethalvectorbornepathogen AT lissinaolga antivectorvaccineprotectsagainstalethalvectorbornepathogen AT hailsrosies antivectorvaccineprotectsagainstalethalvectorbornepathogen AT nuttallpatriciaa antivectorvaccineprotectsagainstalethalvectorbornepathogen |